Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study.

ABSTRACT:

Background

Aspirin use has been associated with a reduced cancer incidence and fewer deaths from cancer. This study examined whether women with breast cancer prescribed aspirin postdiagnosis had improved survival.

Methods

An observational, population cohort study was undertaken using data linkage of cancer registry, dispensed prescriptions and death records in Tayside, Scotland. All community prescriptions for aspirin in women with breast cancer were extracted and use postdiagnosis for each individual examined using Cox's proportional hazard models. The main outcome measures were all-cause mortality and breast cancer-specific mortality.

Results

Four thousand six hundred and twenty-seven patients diagnosed with breast cancer between 1 January 1998 and 31 December 2008

SUBMITTER: Fraser DM 

PROVIDER: S-EPMC4119969 | biostudies-literature | 2014 Jul

REPOSITORIES: biostudies-literature